A review of mortality and surgery in ulcerative colitis: Milestones of the seriousness of the disease

Inflammatory Bowel Diseases

Volumn 19, Issue 9, 2013, Pages 2001-2010

  Bernstein, Charles N ^a   Ng, Siew C ^b   Lakatos, Peter L ^c   Moum, Bjorn ^d   Loftus Jr , Edward V ^e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e MAYO CLINIC   (United States)

Author keywords

Hospitalization; Mortality; Natural history; Surgery; Ulcerative colitis

Indexed keywords

ARTICLE; COLON RESECTION; DISEASE SEVERITY; HOSPITALIZATION; HUMAN; MORBIDITY; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROCTOCOLECTOMY; SURGICAL MORTALITY; ULCERATIVE COLITIS;

COLECTOMY; COLITIS, ULCERATIVE; HUMANS; PROGNOSIS; SURVIVAL RATE;

EID: 84884615621     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e318281f3bb     Document Type: Article

References (61)

1. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut. 1963;4:299-310.
2. Lennard-Jones JE, Vivian AB. Fulminating ulcerative colitis: recent experience in management. BMJ. 1960;2:96-102.
3. Goligher JC. Surgical treatment of ulcerative colitis. BMJ. 1961;1:151-154.
4. Watts JM, DeDombal FT, Watkinson G, et al. Long term prognosis of ulcerative colitis. BMJ. 1966;1:1447-1453.
5. Selinger CP, Leong RW. Mortality from inflammatory bowel diseases. Inflamm Bowel Dis. 2012;18:1566-1572.
6. Jess T, Gamborg M, Munkholm P, et al. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol. 2007;102:609-617.
7. Manninen P, Karvonen AL, Huhtala H, et al. Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland. J Crohns Colitis. 2012;6:524-528.
8. Roberts SE, Williams JG, Yeates D, et al. Mortality in patients admitted to hospital with and without colectomy for ulcerative colitis and Crohn's disease: record linkage studies. BMJ. 2007;335:1033-1036.
9. Nicholls RJ, Clark DN, Kelso L, et al. Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis. Aliment Pharmacol Ther. 2010;31:1310-1321.
10. Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg. 1998;85:800-803.
11. Holubar SD, Larson DW, Dozois EJ, et al. Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach? Dis Colon Rectum. 2009;52:187-192.
12. Holubar SD, Privitera A, Cima RR, et al. Minimally invasive total proctocolectomy with Brooke ileostomy for ulcerative colitis. Inflamm Bowel Dis. 2009;15:1337-1342.
13. Carter FM, McLeod RS, Cohen Z. Subtotal colectomy for ulcerative colitis: complications related to the rectal remnant. Dis Colon Rectum. 1991;34:1005-1009.
14. Hyman NH, Cataldo P, Osler T. Urgent subtotal colectomy for severe inflammatory bowel disease. Dis Colon Rectum. 2005;48:70-73.
15. Alves A, Bouhnil Y, Maylin V, et al. Subtotal colectomy for acute severe colitis: a 20-year experience of a tertiary care center with an aggressive and early surgical policy. J Am Coll Surg. 2003;197:379-385.
16. Faiz O, Warusavitarne J, Bottle A, et al. Nonelective excisional colorectal surgery in English National Health Service Trusts: a study of outcomes from Hospital Episode Statistics Data between 1996 and 2007. J Am Coll Surg. 2010;210:390-401.
17. Arnott IDR, Leiper K, Down C, et al. Outcome of acute severe ulcerative colitis: data from the national UK IBD audit. Gut. 2009;58:A33.
18. Tøttrup A, Erichsen R, Sværke C, et al. Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort study. BMJ Open. 2012;2:e000823.
19. de Silva S, Ma C, Proulx MC, et al. Postoperative complications and mortality following colectomy for ulcerative colitis. Clin Gastroenterol Hepatol. 2011;9:972-980.
20. Kaplan GG, McCarthy EP, Ayanian JZ, et al. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology. 2008;134:680-687.
21. Nguyen GC, Laveist TA, Gearhart S, et al. Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol. 2006;4:1507-1513.
22. Arnott ID, Leiper K, Down C, et al. Outcome of acute severe ulcerative colitis: data from the UK National IBD audit. Gastroenterology. 2010;138:S106.
23. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140: 1785-1794.
24. Pal S, Sahni P, Pande GK, et al. Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India. BMC Gastroenterol. 2005;5:39.
25. Romberg-Camps M, Kuiper E, Schouten L, et al. Mortality in inflammatory bowel disease in the Netherlands 1991-2002: results of a population-based study: the IBD South-Limburg cohort. Inflamm Bowel Dis. 2010;16:1397-1410.
26. Hutfless S, Weng X, Liu L, et al. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology. 2007;133:1779-1786.
27. Farmer RG, Easley KA, Rankin GA. Clinical patterns, natural history, and progression of ulcerative colitis: a long term follow up of 1116 patients. Dig Dis Sci. 1993;38:1137-1146.
28. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut. 1990;31:329-333.
29. Ritchie JK, Powell-Tuck J, Lennard-Jones JE. Clinical outcome of the first ten years of ulcerative colitis and proctitis. Lancet. 1978;1:1140-1143.
30. Sinclair TS, Brunt PW, Mowat NAG. Nonspecific proctocolitis in Northeastern Scotland: a community study. Gastroenterology. 1983;85:1-11.
31. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis-based on results from a regional patient group from the County of Copenhagen. Gut. 1985;26:158-163.
32. Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn Colitis Database. Am J Gastroenterol. 2006;101:1274-1282.
33. Höie O, Wolters F, Riis L, et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide populationbased cohort. Am J Gastroenterol. 2007;102:1692-1701.
34. Höie O, Wolters F, Riis L, et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology. 2007;132:505-515.
35. Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431-440.
36. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992;103: 1444-1451.
37. Lakatos PL, David G, Pandur T, et al. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. J Crohns Colitis. 2011;5:5-13.
38. Lakatos L, Kiss LS, David G, et al. Incidence, disease phenotype at diagnosis and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis. 2011;17:2558-2565.
39. Szamosi T, Banai J, Lakatos L, et al. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and non-smokers with Crohn's disease, while smoking prevents colectomy in UC. Eur J Gastroenterol Hepatol. 2010;22:872-879.
40. Allison J, Herrinton LJ, Liu L, et al. Natural history of severe ulcerative colitis in a community-based health plan. Clin Gastroenterol Hepatol. 2008;6:999-1003.
41. Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121:255-260.
42. Ingle SB, Dhillon S, Harmsen WS, et al. Risk factors for ulcerative colitis surgery in a population-based cohort (abstract). Am J Gastroenterol. 2007; 102:S480-S481.
43. Ananthakrishnan AN, McGinley EL, Binion DG, et al. A nationwide analysis of changes in severity and outcomes of inflammatory bowel disease hospitalizations. J Gastrointest Surg. 2011;15:267-276.
44. Longobardi T, Bernstein CN. Health care resource utilization in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:731-743.
45. Targownik LE, Nugent Z, Singh H, et al. The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort. Am J Gastroenterol. 2012;107:1228-1235.
46. Turner D, Walsh CM, Steinhart AH, et al. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and megaregression. Clin Gastroenterol Hepatol. 2007;5:103-110.
47. Hiwatashi N, Yamazaki H, Kimura M, et al. Clinical course and longterm prognosis of Japanese patients with UC. Gastroenterol Jpn. 1991; 26:312-318.
48. Chow DK, Leong RW, Tsoi KK, et al. Long-term follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol. 2009;104:647-654.
49. Park SH, Kim YM, Yang SK, et al. Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis. 2007;13:278-283.
50. Probert CS, Jayanthi V, Pinder D, et al. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut. 1992;33:687-693.
51. Navaneethan U, Mukewar S, Venkatesh PG, et al. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis. J Crohns Colitis. 2012;6:330-336.
52. Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci. 2010;55:415-420.
53. Langholz E, Munkholm P, Krasilnikoff PA, et al. Inflammatory bowel diseases with onset in childhood: clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol. 1997;32:139-147.
54. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, et al. The Natural history of pediatric ulcerative colitis: a population based cohort study. Am J Gastroenterol. 2009;104:2080-2088.
55. Benchimol EI, Guttmann A, To T, et al. Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007). Inflamm Bowel Dis. 2011;17:2153-2161.
56. Soon IS, Wrobel I, Debruyn JC, et al. Post-op complications following colectomy for UC in children. J Pediatric Gastroenterol Nutr. 2012;54: 763-768.
57. Pola S, Patel D, Ramamoorthy S, et al. Strategies for the care of adults hospitalized for active ulcerative colitis. Clin Gastroenterol Hepatol. 2012;10:1315-1325.
58. Colombel JF, Rutgeerts P, Reinisch W. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141:1194-1201.
59. Khan KJ, Dubinsky MC, Ford AC. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011;106:630-642.
60. Söderlund S, Granath F, Broström O, et al. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology. 2010;138:1697-1703.
61. Rutter MD, Saunders Wilkinson KH. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative BP, colitis. Gastroenterology. 2006;130:1030-1038.